arXiv subjects

Mengtong Hu

Publications and source records attributed to Mengtong Hu.

4 recordsLinked to original sources

arXiv2026

Synthetic Data from Cross-Domain Events for Large-Scale Recommendation Systems

Large-scale recommendation systems operate across diverse domains, yet they face the challenges of data sparsity and noisy implicit feedback. Traditional approaches mitigate this via model-specific knowledge distillation from source domains to a target domain. Inspired by the transformative success of synthetic data generation in large language models (LLMs), we introduce Synthetic Cross-domain Augmentation and Learning for Recommendation (SCALR), a framework that generates synthetic user-item interaction events for a target recommendation domain by leveraging observed events from a source domain. SCALR decomposes cross-domain learning into two modular stages. First, it translates observed user events in source domains by framing event generation as estimating the likelihood that a user would interact with a target-domain item, conditioned on their observed interactions in a source domain. Second, downstream models train on these synthetic events as cross-domain learning objectives, where the synthetic events augment the target domain's training data in a model-agnostic manner. Our approach yields statistically significant improvements in online A/B tests on an industrial recommendation platform. To the best of our knowledge, this is among the first works to explicitly frame cross-domain event transfer as synthetic data generation for recommendation systems.

cs.IR↗

arXiv2024

Privacy enhanced collaborative inference in the Cox proportional hazards model for distributed data

Data sharing barriers are paramount challenges arising from multicenter clinical studies where multiple data sources are stored in a distributed fashion at different local study sites. Particularly in the case of time-to-event analysis when global risk sets are needed for the Cox proportional hazards model, access to a centralized database is typically necessary. Merging such data sources into a common data storage for a centralized statistical analysis requires a data use agreement, which is often time-consuming. Furthermore, the construction and distribution of risk sets to participating clinical centers for subsequent calculations may pose a risk of revealing individual-level information. We propose a new collaborative Cox model that eliminates the need for accessing the centralized database and constructing global risk sets but needs only the sharing of summary statistics with significantly smaller dimensions than risk sets. Thus, the proposed collaborative inference enjoys maximal protection of data privacy. We show theoretically and numerically that the new distributed proportional hazards model approach has little loss of statistical power when compared to the centralized method that requires merging the entire data. We present a renewable sieve method to establish large-sample properties for the proposed method. We illustrate its performance through simulation experiments and a real-world data example from patients with kidney transplantation in the Organ Procurement and Transplantation Network (OPTN) to understand the factors associated with the 5-year death-censored graft failure (DCGF) for patients who underwent kidney transplants in the US.

stat.AP↗

arXiv2023

Theory for identification and Inference with Synthetic Controls: A Proximal Causal Inference Framework

Synthetic control (SC) methods are commonly used to estimate the treatment effect on a single treated unit in panel data settings. An SC is a weighted average of control units built to match the treated unit, with weights typically estimated by regressing (summaries of) pre-treatment outcomes and measured covariates of the treated unit to those of the control units. However, it has been established that in the absence of a good fit, such regression estimator will generally perform poorly. In this paper, we introduce a proximal causal inference framework to formalize identification and inference for both the SC and ultimately the treatment effect on the treated, based on the observation that control units not contributing to the construction of an SC can be repurposed as proxies of latent confounders. We view the difference in the post-treatment outcomes between the treated unit and the SC as a time series, which opens the door to various time series methods for treatment effect estimation. The proposed framework can accommodate nonlinear models, which allows for binary and count outcomes that are understudied in the SC literature. We illustrate with simulation studies and an application to evaluation of the 1990 German Reunification.

stat.ME↗

arXiv2022

Collaborative causal inference with a distributed data-sharing management

Data sharing barriers are paramount challenges arising from multicenter clinical trials where multiple data sources are stored in a distributed fashion at different local study sites. Merging such data sources into a common data storage for a centralized statistical analysis requires a data use agreement, which is often time-consuming. Data merging may become more burdensome when causal inference is of primary interest because propensity score modeling involves combining many confounding variables, and systematic incorporation of this additional modeling in meta-analysis has not been thoroughly investigated in the literature. We propose a new causal inference framework that avoids the merging of subject-level raw data from multiple sites but needs only the sharing of summary statistics. The proposed collaborative inference enjoys maximal protection of data privacy and minimal sensitivity to unbalanced data distributions across data sources. We show theoretically and numerically that the new distributed causal inference approach has little loss of statistical power compared to the centralized method that requires merging the entire data. We present large-sample properties and algorithms for the proposed method. We illustrate its performance by simulation experiments and a real-world data example on a multicenter clinical trial of basal insulin treatment for reducing the risk of post-transplantation diabetes among kidney-transplant patients.

stat.ME↗